Novo Nordisk A/S ADR (NY: NVO )
132.28
+0.74
(+0.56%)
Streaming Delayed Price
Updated: 10:50 AM EDT, Jul 22, 2024
Add to My Watchlist
Press Releases about Novo Nordisk A/S ADR![]()
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
January 08, 2024
![]() ![]() ![]() ![]()
Weight Watchers gains from Oprah’s GLP-1 weight-loss
January 02, 2024
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Can Diabetes, Weight-Loss Drugs Get Even Better?
October 30, 2023
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
MarketBeat Week in Review – 8/7 - 8/11
August 12, 2023
Via MarketBeat
![]()
Novo Nordisk Soars To New High On Weight-Loss Drug Trial Results
August 09, 2023
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|